Skip to content

The Energy Flux Study

Evaluation of Energy Balance at High vs. Low Energy Flux - Energy Flux Study

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01736098
Enrollment
81
Registered
2012-11-29
Start date
2012-08-31
Completion date
2014-08-31
Last updated
2023-02-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Physical Activity

Brief summary

The focus of this randomized clinical trial study is an examination of the effects of maintaining energy balance at different energy fluxes. It will address the primary question: Are there increased health benefits related to body composition and metabolic function associated with maintaining energy balance at a high energy flux as compared to a low energy flux?

Detailed description

We will randomly assign 75 sedentary but healthy individuals to one of two exercise groups or a non-exercise group. We will follow the individuals for 6 months during the intervention period. Both groups will maintain weight by matching energy intake and expenditure (thus the exercise group will consume more calories).

Interventions

OTHEREnergy Flux Exercise Intervention

Comparison of high, medium and low energy flux groups with all groups matching energy intake and expenditure

Sponsors

The Coca-Cola Company
CollaboratorINDUSTRY
University of South Carolina
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
21 Years to 45 Years
Healthy volunteers
Yes

Inclusion criteria

* BMI \<35 * 21-45 years of age * Fasting plasma glucose \<126 mg/dl * Current medications must have been prescribed for 3 or more months and stable * Internet access * Able to participate in a somewhat strenuous physical exercise program * Able to provide informed consent for participation in a research study

Exclusion criteria

* Currently participating in a weight loss or exercise intervention / program * Planning to have weight loss surgery * Weight change \>5 lb in last 12 months * Currently taking any of the following: hormone replacement therapy, beta blockers, allergy shots or systematic corticosteroids (except inhalers) * Significant cardiovascular disease or disorders including but not limited to: serious arrhythmias, cardiomyopathy, congestive heart failure, stroke or transient ischemic cerebral attacks, peripheral vascular disease with intermittent claudication, acute, chronic or recurrent thrombophlebitis, Stage II or Stage III hypertension, myocardial infarction or abnormal exercise stress test. * Medical history with presence of significant conditions or disease that may interfere with study, recent surgery * Pregnant or actively trying to become pregnant * Gave birth in the last 12 months or \<6 months post-lactation * \> 90th percentile on the Brief Symptom Inventory \[BSI\] * Planning to move from the area in the next 8 months * Other medical, psychiatric or behavioral factors that in the judgment of the principal investigator may interfere with study participation or the ability ot follow the intervention protocol. Upon identification of individuals with suicidal ideation or other dangerous conditions, the individual will be contacted and told to immediately go to a medical emergency room.

Design outcomes

Primary

MeasureTime frameDescription
Changes in anthropometricsFrom baseline to 6 monthsChanges in lean and fat mass

Other

MeasureTime frameDescription
Changes in energy expenditureFrom Baseline to 6 months
Changes in markers of systemic inflammationBaseline to 6 monthsChange in tumor necrosis factor-alpha \[TNF-alpha\]
Changes in triglyceride / cholesterol transportBaseline to 6 monthsChange in Apolipoprotein E \[ApoE\]
Changes in energy intakeFrom Baseline to 6 months
Changes in carbohydrate metabolismBaseline to 6 monthsChange in serum insulin
Changes in blood lipidsBaseline to 6 monthsChange in serum triglycerides
Change in functional measurementsBaseline to 6 monthsChange in cardiorespiratory fitness through graded exercise testing
Change in the index of fatty acid metabolismBaseline to 6 monthsChange in serum 3 hydroxybutyric acid

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026